Your fact-checks will appear here
Comparative remission of type 2 diabetes across lifestyle programs, GLP-1 receptor agonists, and metabolic/bariatric surgery
Randomized-trial evidence shows that structured intensive lifestyle programs can induce remission of type 2 diabetes in a meaningful minority of participants, GLP‑1 receptor agonists produce larger sh...
Randomized trial evidence and several recent systematic reviews show that clinically meaningful weight loss achieved with GLP‑1 and GLP‑1/GIP agonists is frequently lost after drug withdrawal—with mos...
There are legitimate, FDA‑approved treatments for type 2 diabetes that have evidence of producing remission—most strongly metabolic/bariatric surgery and intentional substantial weight loss through st...
Type 2 diabetes is treated with a layered, evidence-based toolkit that begins with lifestyle intervention and metformin and expands to multiple drug classes—GLP‑1 receptor agonists, SGLT2 inhibitors, ...
Randomized‑controlled trials (RCTs) show the strongest, most durable remission signals for metabolic/bariatric surgery, while structured intensive weight‑loss programs and several non‑surgical dietary...
Type 2 diabetes (T2D) can be pushed into remission or markedly better glycemic control by several proven strategies: intensive weight-loss–focused lifestyle programs, metabolic/bariatric surgery, shor...
Younger patients with shorter known diabetes duration, lower baseline HbA1c and a low requirement for glucose‑lowering medications (especially absence of insulin or sulfonylureas) have the highest pro...